Drug Substance (CDMO/CRO)
Drug Product (CMO)

Find and compare companies providing:
Contract pharmaceutical outsourcing services


Filter by expertise, certification, scale and geography to shortlist trusted contract pharmaceutical service providers for effective pharma outsourcing.

Currently there are no contract services that you choosen. If you can supply others with this services, this is your chance to get listed first!

What is a CDMO, CMO, and CRO?

Outsourcing terms are often used interchangeably, but they describe different scopes. This page is a directory for CDMO services and CMO services, with guidance to help you route correctly.

CDMO

Development + manufacturing: process development, scale-up, tech transfer, validation, and GMP production.

CMO

Manufacturing execution: GMP manufacturing, packaging, and supply continuity once the process is established.

CRO

Research and clinical support: analytical/bioanalytical work, clinical services, and research-heavy deliverables.

Practical rule: ignore the label and validate the scope (what’s in-house, what’s routine for them, and what they can support at your stage).

How to choose the right outsourcing model

Browsing suppliers is the easy part. Choosing the right outsourcing setup is where projects win or stall. Use the sections below to route correctly and approach suppliers with clear requirements.

Decision tree: where should you start?

This is a practical routing checklist (not a textbook). Use it to avoid contacting the wrong type of supplier.

  1. What are you outsourcing?
    Active ingredient / API / upstream manufacturing → start with Drug Substance (CDMO/CRO)
    Finished dosage form / fill-finish / packaging → start with Drug Product (CMO)

  2. Do you need development or only manufacturing?
    Development + manufacturing → shortlist CDMO services
    Manufacturing only (process already defined) → shortlist CMO services

  3. Any specialized constraints?
    Sterile manufacturing, high potency/containment (OEB), cold chain, controlled substances → shortlist specialized facilities first

  4. Which stage are you in?
    Early development / clinical → flexibility, small batches, fast iteration
    Commercial → capacity, quality maturity, supply reliability, documentation readiness

How outsourcing typically works

A smooth outsourcing project is mostly about clarity and preparation. These steps help you move faster and reduce rework.

  1. Define requirements (product type, stage, markets, batch sizes, timelines)

  2. Build a shortlist (capability fit + region + quality requirements)

  3. Share a concise project brief (and sign an NDA if needed)

  4. Feasibility & proposal (timeline, costs, risks, required inputs)

  5. Quality assessment (documentation review, audit readiness)

  6. Agreement setup (quality agreement, responsibilities, change control)

  7. Tech transfer (process, analytics, materials, packaging components)

  8. Validation & routine supply (as required by stage and markets)

Supplier evaluation checklist

Suppliers respond faster and more accurately when your brief is clear. Use this checklist before outreach.

What to prepare before contacting suppliers

  • Product type (Drug Substance / Drug Product) and dosage form (if applicable)
  • Development stage (preclinical / clinical / commercial)
  • Batch sizes and annual demand estimate
  • Target markets (EU/US/other) and quality expectations (GMP, documentation)
  • Key constraints (sterile, containment/OEB, cold chain, controlled substances)
  • Timeline (tech transfer, first batch, launch window)

Questions to ask during evaluation

  • Capability & experience: similar products? similar scales? which steps are in-house?
  • Quality & compliance: inspections/markets supported, CAPA/change control maturity
  • Capacity & timelines: realistic lead times, bottlenecks, mitigation plan
  • Communication: ownership, cadence, escalation, documentation standards
RFQ template: what to include in your first message

If your first message is vague, quotes will be vague. Include the items below to speed up proposals.

  • Scope: Drug Substance or Drug Product; development needed or manufacturing only
  • Stage: clinical vs commercial; target markets (FDA/EMA/others)
  • Volumes: batch sizes + annual demand estimate
  • Constraints: sterile, containment/OEB, cold chain, controlled substances
  • Timeline: desired start date, first batch, launch window
  • Quality: required certifications, audit expectations, documentation level

FAQ: CDMO & CMO outsourcing

Quick answers for common sourcing questions. If you’re unsure, use the open inquiry option above and include your constraints.

Should I choose a CDMO or a CMO?

Choose a CDMO when you need development work (process development, scale-up, tech transfer support) along with manufacturing. Choose a CMO when your process is established and you mainly need manufacturing execution and supply.

What is the difference between Drug Substance and Drug Product?

Drug Substance is the active ingredient (API). Drug Product is the finished dosage form patients use (tablets, capsules, injectables, sprays, creams, etc.).

When should I involve a CRO?

Involve a CRO when your scope includes research-heavy work (bioanalysis, clinical services, specialized analytical tasks). Some CDMOs also provide CRO-like services; validate what’s truly in-house.

Can one supplier handle both Drug Substance and Drug Product?

Sometimes yes, but many suppliers specialize. The fastest approach is usually to shortlist based on the exact stage and manufacturing scope you need now, then expand if you want a single long-term partner.

How do I shortlist suppliers quickly without missing a good option?

Start with scope (Drug Substance vs Drug Product), then filter by constraints (sterile, containment/OEB), target markets (FDA/EMA), and scale (batch size). Only then compare “nice-to-haves.”

What affects price the most in outsourcing quotes?

The biggest drivers are development effort, complexity (sterile/containment), batch size, analytical requirements, validation scope, and documentation/market requirements. Clear inputs reduce pricing uncertainty.

Do I need an NDA before contacting a CDMO/CMO?

Often yes if you need to share sensitive details. Many suppliers can review a high-level brief without an NDA, then sign one before detailed transfer.

How do I verify GMP capabilities?

Check relevant certifications/inspections for your target markets, ask what’s in-scope at the specific facility, and validate quality systems (deviations/CAPA, change control, batch record/release workflow). Audits are common for final confirmation.

How long does it take to onboard a new outsourcing partner?

It depends on stage and complexity. Expect time for feasibility, quality assessment, agreements, and tech transfer. Sterile, high potency, or complex biologics typically require longer lead times.

What should I include in an open inquiry to get better matches?

Include product type (Drug Substance/Drug Product), stage, markets, batch sizes, key constraints (sterile/OEB/cold chain), and timeline. The more specific you are, the fewer irrelevant matches you get.